Ildong Pharmaceutical Co., Ltd.
KRX:249420.KS
14050 (KRW) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 53,258.173 | 52,145.854 | 135,586.333 | 85,563.922 | 89,959.339 | 75,937.468 | 39,943.786 | 19,904.841 |
| Short Term Investments
| 28,020.839 | 26,600 | 19,095 | 600 | 600 | 1,698.784 | 376.062 | 71.168 |
| Cash and Short Term Investments
| 81,279.012 | 78,745.854 | 154,681.333 | 86,163.922 | 90,559.339 | 77,636.252 | 40,319.848 | 19,976.009 |
| Net Receivables
| 67,349.307 | 102,793.605 | 62,324.967 | 55,732.12 | 71,687.706 | 79,619.24 | 104,721.445 | 137,522.474 |
| Inventory
| 84,623.479 | 98,248.803 | 82,587.409 | 89,226.55 | 69,744.233 | 53,200.023 | 59,983.472 | 61,201.631 |
| Other Current Assets
| 2,429.58 | 2,246.605 | 1,956.524 | 2,120.516 | 1,376.028 | -0 | -0 | -0 |
| Total Current Assets
| 235,681.378 | 282,034.868 | 301,550.233 | 233,243.108 | 233,367.305 | 210,455.515 | 205,024.764 | 218,700.114 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 256,379.647 | 255,316.953 | 247,789.74 | 256,418.752 | 259,520.623 | 227,484.956 | 228,283.768 | 236,342.661 |
| Goodwill
| 5,527.039 | 5,527.039 | 5,527.039 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 36,583.804 | 41,593.689 | 61,100.021 | 63,071.75 | 69,608.342 | 88,169.37 | 99,860.951 | 76,041.182 |
| Goodwill and Intangible Assets
| 42,110.843 | 47,120.728 | 66,627.06 | 63,071.75 | 69,608.342 | 88,169.37 | 99,860.951 | 76,041.182 |
| Long Term Investments
| 22,184.585 | -5,205.039 | 3,336.848 | 21,074.844 | 10,984.102 | 12,058.403 | 11,482.182 | 1,989.731 |
| Tax Assets
| 53,888.271 | 43,822.227 | 66,015.9 | 24,935.362 | 32,262.717 | 20,117.034 | 15,464.803 | 11,515.453 |
| Other Non-Current Assets
| 1,016.133 | 32,720.477 | 23,650.581 | 6,533.299 | 6,979.764 | 6,384.085 | 4,510.806 | 5,764.691 |
| Total Non-Current Assets
| 375,579.479 | 373,775.346 | 407,420.129 | 372,034.006 | 379,355.548 | 354,213.848 | 359,602.51 | 331,653.718 |
| Total Assets
| 611,260.857 | 655,810.214 | 708,970.363 | 605,277.114 | 612,722.853 | 564,669.363 | 564,627.274 | 550,353.832 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 50,249.537 | 46,098.773 | 38,334.279 | 35,987.672 | 39,764.264 | 20,582.695 | 26,776.595 | 30,980.755 |
| Short Term Debt
| 186,361.65 | 148,361.007 | 134,435.071 | 92,356.484 | 110,736.275 | 94,400 | 85,400 | 66,400 |
| Tax Payables
| 68.304 | 3,384.057 | 3,352.645 | 3,805.099 | 4,005.117 | 6,286.505 | 8,030.946 | 11,057.939 |
| Deferred Revenue
| 2,708.919 | 4,776.315 | 191,371.251 | 56,666.192 | 61,341.986 | 6,286.505 | 45,235.907 | 11,057.939 |
| Other Current Liabilities
| 74,909.91 | 117,054.307 | 0.001 | 0.001 | 0 | 41,628.106 | 0 | 34,089.786 |
| Total Current Liabilities
| 314,230.016 | 316,290.402 | 364,140.601 | 185,010.349 | 211,842.525 | 162,897.306 | 157,412.502 | 142,528.48 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 14,825.178 | 59,386.665 | 91,720.302 | 74,499.899 | 55,185.411 | 36,000 | 45,000 | 64,000 |
| Deferred Revenue Non-Current
| 16,654.303 | 0 | 0 | 0 | -30,626.68 | 0 | -21,150.507 | -22,739.23 |
| Deferred Tax Liabilities Non-Current
| 1.432 | 6.063 | 0 | 0 | 30,626.68 | 0 | 21,150.507 | 22,739.23 |
| Other Non-Current Liabilities
| 91,284.351 | 81,902.847 | 92,524.684 | 91,219.483 | 92,803.404 | 88,947.229 | 77,142.15 | 75,411.64 |
| Total Non-Current Liabilities
| 122,765.264 | 141,295.575 | 184,244.986 | 165,719.382 | 147,988.815 | 124,947.229 | 122,142.15 | 139,411.64 |
| Total Liabilities
| 436,995.279 | 457,585.977 | 548,385.588 | 350,729.731 | 359,831.34 | 287,844.535 | 279,554.652 | 281,940.12 |
| Equity: | ||||||||
| Preferred Stock
| 5,115.132 | 5,646.157 | 6,377.375 | 0 | 0 | 0 | 0 | 49.705 |
| Common Stock
| 28,062.501 | 26,803.285 | 23,803.285 | 23,803.285 | 22,670.452 | 21,591.413 | 19,629.292 | 17,845.253 |
| Retained Earnings
| -60,840.115 | -211,102.186 | -81,950.857 | 14,855.878 | -7,172.212 | 15,965.605 | 27,386.842 | 11,794.935 |
| Accumulated Other Comprehensive Income/Loss
| 31,268.374 | 920.543 | 3,459.069 | 8,939.556 | 2,768.439 | 15,570.072 | 5,895.967 | -49.705 |
| Other Total Stockholders Equity
| 165,936.829 | 368,975.849 | 201,219.645 | 206,948.664 | 234,624.834 | 223,697.737 | 232,160.521 | 238,773.523 |
| Total Shareholders Equity
| 169,542.721 | 191,243.648 | 152,908.517 | 254,547.383 | 252,891.513 | 276,824.828 | 285,072.622 | 268,413.711 |
| Total Equity
| 174,265.578 | 198,224.237 | 160,584.775 | 254,547.383 | 252,891.513 | 276,824.828 | 285,072.622 | 268,413.711 |
| Total Liabilities & Shareholders Equity
| 611,260.857 | 655,810.214 | 708,970.363 | 605,277.114 | 612,722.853 | 564,669.363 | 564,627.274 | 550,353.832 |